Changes in differential gene expression in fibroblast cells from patients with triple A syndrome under oxidative stress

Hormone and Metabolic Research

Volumn 45, Issue 2, 2013, Pages 102-108

  Koehler, K ^a   End, K ^a,b   Kind, B ^a   Landgraf, D ^a   Mitzscherling, P ^a   Huebner, A ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

Author keywords

ALADIN; nucleoporin; oxidative stress; PCR array

Indexed keywords

24 DEHYDROCHOLESTEROL REDUCTASE; NUCLEOPORIN; NUCLEOPORIN ALADIN; NUDIX TYPE MOTIF 1; PARAQUAT; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2; PROTEIN; PROTEIN BNIP3; SCAVENGER RECEPTOR CLASS A MEMBER 3; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG;

ALLGROVE SYNDROME; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; FIBROBLAST CULTURE; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTRON; MISSENSE MUTATION; NONSENSE MUTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

ADRENAL INSUFFICIENCY; CELL LINE; CELLS, CULTURED; ESOPHAGEAL ACHALASIA; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; OXIDANTS; OXIDATIVE STRESS; PARAQUAT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN;

EID: 84874107879     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1331196     Document Type: Article

References (40)

1. Allgrove J., Clayden G. S., Grant D. B., Macaulay J. C. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet: 1978; 1 1284 1286
2. Handschug K., Sperling S., Yoon S. J., Hennig S., Clark A. J., Huebner A. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet: 2001; 10 283 290
3. Tullio-Pelet A., Salomon R., Hadj-Rabia S., Mugnier C., de Laet M. H., Chaouachi B., Bakiri F., Brottier P., Cattolico L., Penet C., Bégeot M., Naville D., Nicolino M., Chaussain J. L., Weissenbach J., Munnich A., Lyonnet S. Mutant WD-repeat protein in triple-A syndrome. Nat Genet: 2000; 26 332 335
4. Cronshaw J. M., Krutchinsky A. N., Zhang W., Chait B. T., Matunis M. J. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol: 2002; 158 915 927
5. Rabut G., Doye V., Ellenberg J. Mapping the dynamic organization of the nuclear pore complex inside single living cells. Nat Cell Biol: 2004; 6 1114 1121
6. Hirano M., Furiya Y., Asai H., Yasui A., Ueno S. ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proc Natl Acad Sci USA: 2006; 103 2298 2303
7. Storr H. L., Kind B., Parfitt D. A., Chapple J. P., Lorenz M., Koehler K., Huebner A., Clark A. J. Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol: 2009; 23 2086 2094
8. Kind B., Koehler K., Krumbholz M., Landgraf D., Huebner A. Intracellular ROS level is increased in fibroblasts of triple A syndrome patients. J Mol Med: 2010; 88 1233 1242
9. th ed. New York Oxford University Press: 2007
10. Sayre L. M., Moreira P. I., Smith M. A., Perry G. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita: 2005; 41 143 164
11. Sas K., Robotka H., Toldi J., Vécsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci: 2007; 257 221 239
12. Vallet A. E., Verschueren A., Petiot P., Vandenberghe N., Nicolino M., Roman S., Pouget J., Vial C. Neurological features in adult Triple-A (Allgrove) syndrome. J Neurol Sci: 2012; 259 39 46
13. Hoepken H. H., Gispert S., Azizov M., Klinkenberg M., Ricciardi F., Kurz A., Morales-Gordo B., Bonin M., Riess O., Gasser T., Kögel D., Steinmetz H., Auburger G. Parkinson patient fibroblasts show increased alpha-synuclein expression. Exp Neurol: 2008; 212 307 313
14. Pedersen C. B., Zolkipli Z., Vang S., Palmfeldt J., Kjeldsen M., Stenbroen V., Schmidt S. P., Wanders R. J., Ruiter J. P., Wibrand F., Tein I., Gregersen N. Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria. J Inherit Metab Dis: 2010; 33 211 222
15. Campanella A., Privitera D., Guaraldo M., Rovelli E., Barzaghi C., Garavaglia B., Santambrogio P., Cozzi A., Levi S. Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties. Hum Mol Genet: 2012; 21 4049 4059
16. Auburger G., Klinkenberg M., Drost J., Marcus K., Morales-Gordo B., Kunz W. S., Brandt U., Broccoli V., Reichmann H., Gispert S., Jendrach M. Primary skin fibroblasts as a model of Parkinson's disease. Mol Neurobiol: 2012; 46 20 27
17. Peri A., Danza G., Benvenuti S., Luciani P., Deledda C., Rosati F., Cellai I., Serio M. New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm. Front Neuroendocrinol: 2009; 30 119 129
18. Kuehnle K., Crameri A., Kälin R. E., Luciani P., Benvenuti S., Peri A., Ratti F., Rodolfo M., Kulic L., Heppner F. L., Nitsch R. M., Mohajeri M. H. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Mol Cell Biol: 2008; 28 539 550
19. Battista M. C., Roberge C., Martinez A., Gallo-Payet N. 24-dehydrocholesterol reductase/seladin-1: a key protein differentially involved in adrenocorticotropin effects observed in human and rat adrenal cortex. Endocrinology: 2009; 150 4180 4190
20. Wierstra I., Alves J. FOXM1 a typical proliferation-associated transcription factor. Biol Chem: 2007; 388 1257 1274
21. Wang Z., Ahmad A., Li Y., Banerjee S., Kong D., Sarkar F. H. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev: 2010; 36 151 156
22. Park H. J., Carr J. R., Wang Z., Nogueira V., Hay N., Tyner A. L., Lau L. F., Costa R. H., Raychaudhuri P. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J: 2009; 28 2908 2918
23. Li S. K., Smith D. K., Leung W. Y., Cheung A. M., Lam E. W., Dimri G. P., Yao K. M. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J Biol Chem: 2008; 283 16545 16553
24. McLennan A. G. The Nudix hydrolase superfamily. Cell Mol Life Sci: 2006; 63 123 143
25. Nakabeppu Y., Kajitani K., Sakamoto K., Yamaguchi H., Tsuchimoto D. MTH1 an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides. DNA Repair: 2006; 5 761 772
26. Greaves D. R., Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J Lipid Res: 2009; 50 S282 S286
27. Aguilar-Gaytan R., Mas-Oliva J. Oxidative stress impairs endocytosis of the scavenger receptor class A. Biochem Biophys Res Commun: 2003; 305 510 517
28. Boyd J. M., Malstrom S., Subramanian T., Venkatesh L. K., Schaeper U., Elangovan B., D'Sa-Eipper C., Chinnadurai G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell: 1994; 79 341 351
29. Zhang J., Ney P. A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ: 2009; 16 939 946
30. Burton T. R., Gibson S. B. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ: 2009; 16 515 523
31. Rikka S., Quinsay M. N., Thomas R. L., Kubli D. A., Zhang X., Murphy A. N., Gustafsson ÅB. Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ: 2011; 18 721 731
32. Bermudez O., Pagès G., Gimond C. The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physiol: 2010; 299 C189 C202
33. Wancket L. M., Frazier W. J., Liu Y. Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease. Life Sci: 2012; 90 237 248
34. Wu J. J., Bennett A. M. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling. J Biol Chem: 2005; 280 16461 16466
35. Zhou J. Y., Liu Y., Wu G. S. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Cancer Res: 2006; 66 4888 4894
36. Musiek E. S., Milne G. L., McLaughlin B., Morrow J. D. Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity. Brain Pathol: 2005; 15 149 158
37. Choi S. H., Aid S., Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci: 2009; 30 174 181
38. Ding Z. C., Ni F. Y., Huang Z. X. Neuronal growth-inhibitory factor (metallothionein-3): structure-function relationships. FEBS J: 2010; 277 2912 2920
39. Howells C., West A. K., Chung R. S. Neuronal growth-inhibitory factor (metallothionein-3): evaluation of the biological function of growth-inhibitory factor in the injured and neurodegenerative brain. FEBS J: 2010; 277 2931 2939
40. Sogawa C. A., Asanuma M., Sogawa N., Miyazaki I., Nakanishi T., Furuta H., Ogawa N. Localization, regulation, and function of metallothionein-III/ growth inhibitory factor in the brain. Acta Med Okayama: 2001; 55 1 9